Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma
2014 ◽
Vol 34
(2)
◽
pp. 141-147
2002 ◽
Vol 29
(6 Suppl 19)
◽
pp. 61-62
◽
2020 ◽
Vol 77
(1)
◽
pp. 77-88
◽
2010 ◽
Vol 53
(10)
◽
pp. 620
Keyword(s):